Our BioID2-based proximity labeling approach also revealed several other EMP3-proximal proteins, including GBM-relevant membrane receptors (e.g., CD44, integrins, SLCs), signaling adaptors, and other trafficking regulators. This evidence concerns the gene EMP3 and glioblastoma.